Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|October 2, 2021
Covid-19: Spreading vaccine "misinformation" puts licence at risk, US boards tell physiciansPeter Doshi
BMJ (Clinical Research Ed.)|March 28, 2015
Speeding new antibiotics to market: a fake fix?Peter Doshi
BMJ (Clinical Research Ed.)|June 14, 2014
EMA policy on transparency is "strikingly" similar to deal struck with drug company, say expertsPeter Doshi
BMJ (Clinical Research Ed.)|November 1, 2023
The FDA and Moderna's cosy relationship: how lax rules enable a revolving door culturePeter Doshi
Bulletin of the World Health Organization|July 8, 2011
The elusive definition of pandemic influenzaPeter Doshi
BMJ (Clinical Research Ed.)|June 19, 2025
Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca's billion dollar drugPeter Doshi
BMJ (Clinical Research Ed.)|July 1, 2024
Revolving door: You are free to influence us "behind the scenes," FDA tells staff leaving for industry jobsPeter Doshi
BMJ (Clinical Research Ed.)|August 22, 2013
EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstoodPeter Doshi
BMJ (Clinical Research Ed.)|October 22, 2020
Will covid-19 vaccines save lives? Current trials aren't designed to tell usPeter Doshi
BMJ (Clinical Research Ed.)|September 18, 2020
Covid-19: Do many people have pre-existing immunity?Peter Doshi
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|October 2, 2021
Covid-19: Spreading vaccine "misinformation" puts licence at risk, US boards tell physiciansPeter Doshi
BMJ (Clinical Research Ed.)|March 28, 2015
Speeding new antibiotics to market: a fake fix?Peter Doshi
BMJ (Clinical Research Ed.)|June 14, 2014
EMA policy on transparency is "strikingly" similar to deal struck with drug company, say expertsPeter Doshi
BMJ (Clinical Research Ed.)|November 1, 2023
The FDA and Moderna's cosy relationship: how lax rules enable a revolving door culturePeter Doshi
Bulletin of the World Health Organization|July 8, 2011
The elusive definition of pandemic influenzaPeter Doshi
BMJ (Clinical Research Ed.)|June 19, 2025
Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca's billion dollar drugPeter Doshi
BMJ (Clinical Research Ed.)|July 1, 2024
Revolving door: You are free to influence us "behind the scenes," FDA tells staff leaving for industry jobsPeter Doshi
BMJ (Clinical Research Ed.)|August 22, 2013
EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstoodPeter Doshi
BMJ (Clinical Research Ed.)|October 22, 2020
Will covid-19 vaccines save lives? Current trials aren't designed to tell usPeter Doshi
BMJ (Clinical Research Ed.)|September 18, 2020
Covid-19: Do many people have pre-existing immunity?Peter Doshi
Pageof 15